Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 19 Rectal Neoplasms 11 Colorectal Neoplasms 11 Colonic Neoplasms 11 Central Nervous System Neoplasms 8 Stomach Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Melanoma 5 Lung Neoplasms 4 Liver Neoplasms 4 Kidney Neoplasms 4 Carcinoma, Hepatocellular 4 Head and Neck Neoplasms 3 Fallopian Tube Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Ovarian Epithelial 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Recurrence 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Neuroblastoma 2 Lymphatic Metastasis 2 Glioblastoma 2 Breast Neoplasms, Male 2 Astrocytoma 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Oesophagogastric Cancer × Chemotherapy, Adjuvant × Clear all

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡